Celyad Oncology SA (CYAD): key financial figures for fiscal year 2025 (in EUR), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- €21.0K
- Net Income/Loss (FY2025)
- €830.0K
- Total Assets (FY2025)
- €4.3M
- Total Equity (FY2025)
- €2.4M
- Cash Flows from Operating Activities (FY2025)
- -€6.9M
Source: Celyad Oncology SA annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
